Selective ACAT Inhibitors as Promising Antihyperlipidemic, Antiatherosclerotic and Anti-Alzheimer Drugs

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|3|6|576-584

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.3, Iss.6, 2003-09, pp. : 576-584

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New Anti-Alzheimer Drugs from Biodiversity: The Role of the Natural Acetylcholinesterase Inhibitors

By  

Mini Reviews in Medicinal Chemistry, Vol. 5, Iss. 10, 2005-10 ,pp. : 915-926

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Alzheimer Therapeutic Drugs Targeting γ-Secretase

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 5, 2016-02 ,pp. : 549-557

Bentham Science Publishers

Access to resources Recommend Favorite

Squalene Synthase Inhibitors: An Update on the Search for New Antihyperlipidemic and Antiatherosclerotic Agents

By  

Current Medicinal Chemistry, Vol. 18, Iss. 29, 2011-10 ,pp. : 4418-4439

Bentham Science Publishers

Access to resources Recommend Favorite

Animal models to evaluate anti‐atherosclerotic drugs

By  

Fundamental & Clinical Pharmacology, Vol. 29, Iss. 4, 2015-08 ,pp. : 329-340

John Wiley & Sons Inc

Access to resources Recommend Favorite

Direct Anti-Atherosclerotic Therapy; Development of Natural Anti-Atherosclerotic Drugs Preventing Cellular Cholesterol Retention

By  

Current Pharmaceutical Design, Vol. 19, Iss. 33, 2013-10 ,pp. : 5909-5928

Bentham Science Publishers

Access to resources Recommend Favorite